AMBAGON THERAPEUTICS
AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.
AMBAGON THERAPEUTICS
Industry:
Biotechnology Medical Product Research
Founded:
2020-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.ambagontx.com
Total Employee:
11+
Status:
Active
Contact:
650-231-5131
Total Funding:
148 M USD
Technology used in webpage:
Google Maps Google Google Cloud
Similar Organizations
AnHeart Therapeutics
AnHeart Therapeutics is a developer of innovative pharmaceutical products.
Aristea Therapeutics
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Atomo Coffee
Atomo Coffee is a developer of molecular coffee.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Board_observer
2020-01-01
Board_member
Board_member
2020-08-01
Current Employees Featured
Lucas Brunsveld Co-Founder @ AmbAgon Therapeutics
Co-Founder
Christian Ottmann Founder, CTO @ AmbAgon Therapeutics
Founder, CTO
2020-07-01
Michelle Arkin Co-Founder @ AmbAgon Therapeutics
Co-Founder
Scott Clarke CEO @ AmbAgon Therapeutics
CEO
Nancy Pryer Chief Scientific Officer @ AmbAgon Therapeutics
Chief Scientific Officer
Bryan Miller CFO @ AmbAgon Therapeutics
CFO
2020-01-01
Founder
Investors List
Mission BioCapital
Mission BioCapital investment in Series A - AmbAgon Therapeutics
RA Capital Management
RA Capital Management investment in Series A - AmbAgon Therapeutics
Surveyor Capital
Surveyor Capital investment in Series A - AmbAgon Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Series A - AmbAgon Therapeutics
Inkef
Inkef investment in Series A - AmbAgon Therapeutics
Droia Ventures
Droia Ventures investment in Series A - AmbAgon Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - AmbAgon Therapeutics
Nextech Invest
Nextech Invest investment in Series A - AmbAgon Therapeutics
Official Site Inspections
http://www.ambagontx.com Semrush global rank: 4.71 M Semrush visits lastest month: 1.96 K
- Host name: 3.121.247.35.bc.googleusercontent.com
- IP address: 35.247.121.3
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "AmbAgon Therapeutics"
About - Ambagon Therapeutics
Steve Davidsen, Ph.D., is Vice President, Oncology Discovery in AbbVie’s R&D organization, where he is responsible for discovery and research efforts of AbbVie’s Oncology programs. He …See details»
Ambagon Therapeutics • The 14-3-3 Molecular Glue …
Ambagon’s approach selectively augments the endogenous tumor suppression activity of 14-3-3 proteins bound to transcription factors and oncoproteins that have proven challenging to modulate with conventional approaches. …See details»
AmbAgon Therapeutics - Crunchbase Company Profile …
AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein.See details»
Ambagon Therapeutics Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ambagon Therapeutics Inc. of Daly City, CA. Get the latest business insights from Dun & Bradstreet.See details»
Ambagon Therapeutics - LinkedIn
Ambagon Therapeutics | 4,570 followers on LinkedIn. Expanding the druggable proteome to drug intrinsically disordered proteins. | Ambagon is discovering and developing small molecule …See details»
Our Science - Ambagon Therapeutics
How 14-3-3 Works. 14-3-3 proteins interact with their clients in a specific binding groove through recognition of phosphorylated serine- or threonine-containing motifs, conferring order upon …See details»
Ambagon Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Ambagontx.com. Startups | Holding Company | 2020 | California, United States | 10-50 | ambagontx.com. Last update 10 Dec 2024. Overview. Pipeline. Deal. Translational Medicine. …See details»
Ambagon Therapeutics - PitchBook
Ambagon Therapeutics General Information Description. Developer of small-molecule cancer drugs designed to stabilize the direct interaction of oncogenic proteins. The company's drugs …See details»
Ambagon Therapeutics: Contact Details and Business Profile
Ambagontx.com; 3 773297XXXX; 415859XXXX; 773983XXXX; Nancy Pryer Chief Scientific Officer at Ambagon Therapeutics Berkeley, CA, US View. 2 pacbell.net; ambagontx.com; 2 …See details»
Ambagon Therapeutics - VentureRadar
"Ambagon Therapeutics develops first-in-class small-molecule therapeutics for cancer by augmenting the tumor-suppressing functions of the 14-3-3 protein, a truly novel approach for …See details»
Ambagon Therapeutics - Craft
Ambagon Therapeutics has 5 employees across 2 locations and $92.2 m in total funding,. See insights on Ambagon Therapeutics including office locations, competitors, revenue, financials, …See details»
Ambagon Therapeutics - Overview, News & Similar companies
Jan 6, 2022 Ambagon Therapeutics wordt gelanceerd met $ 85 miljoen Serie A om baanbrekend moleculair lijmplatform en voortgangspijplijn te bevorderen SAN FRANCISCO--(BUSINESS …See details»
Ambagon Therapeutics - Lifesciences @ Work
AmbAgon develops first-in-class small-molecule therapeutics for breast cancer by augmenting the tumor-suppressing functions of the 14-3-3 protein. Our industry-trained founders – Christian …See details»
AmbAgon Therapeutics - Work in biotech
Ambagon Therapeutics is enhancing the activity of tumor suppressors by creating cancer molecule therapeutics. 14-3-3 proteins are adaptor proteins that play a key role in a large …See details»
Ambagon Therapeutics Company Overview, Contact Details
May 27, 2022 Cutting-Edge Technology Ambagon Therapeutics leverages a tech stack that includes Google Cloud, Python, and PHP to develop innovative small molecule cancer drugs. …See details»
Join Us - Ambagon Therapeutics
Join our team today. Ambagon was inspired by the world-class research in the laboratories of our co-founders, combining expertise in structural biology, chemistry and biophysics of 14-3-3 …See details»
AmbAgon Therapeutics | CipherBio
Explore AmbAgon Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Ambagon Therapeutics Email Formats & Email Address Examples
Frequently Asked Questions What does Ambagon Therapeutics do? Ambagon Therapeutics was founded in 2020. The company's main headquarters is located in 2001 Junipero Serra Blvd …See details»
Office of the Texas Governor | Greg Abbott
Jan 3, 2025 “Earlier this week, Texas Department of Public Safety troopers identified and arrested four vicious TdA gang members attempting to illegally cross the border from Mexico …See details»
Texas border town wins $13M grant for environment work - The …
3 days ago Presidio, northwest of Big Bend National Park, will get dedicated green spaces along bike lanes and pedestrian streets, plant thousands of native trees and establish a high-school …See details»